Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol MAP3K11 contributors: mct/ - updated : 20-05-2016
HGNC name mitogen-activated protein kinase kinase kinase 11
HGNC id 6850
DNA
TYPE functioning gene
STRUCTURE 16.50 kb     10 Exon(s)
10 Kb 5' upstream gene genomic sequence study
MAPPING cloned Y linked N status confirmed
Map cen - PGA@ - FTH1 - SCGB1A1 - AHNAK - ROM1 - SLC3A2 - CHRM1 - COX8A - MARK2 - FKBP2 - PLCB2 - [PYGM PYGM ,SF1 ] - FAU - CAPN1 - [MAP3K11 ,RELA ] - (D11S1956E ,D11S951E ) - FOSL1 - (SLC29A2 ,D11S913 ) - ACTN3 - PC - D11S703 - GSTP1 - D11S987 - qter
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
10 - 3574 92 847 - 2010 20514022
EXPRESSION
Type widely
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Digestivemouthtongue  highly
 salivary gland   highly
Lymphoid/Immunespleen   highly
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES basic
STRUCTURE
motifs/domains
  • glycine rich and N-terminal Src-homology 3 (SH3) domain (is autoinhibited through its SH3 domain)
  • a kinase domain
  • a leucine zipper
  • a Cdc42/Rac interactive binding (CRIB) motif
  • a catalytic domain (in MLK1 domain)
  • C-terminal proline–serine–threonine rich domain, with signature sequences of both Ser/Thr and Tyr kinases in the catalytic domain
  • conjugated PhosphoP
    HOMOLOGY
    interspecies homolog to murine Map3k11
    Homologene
    FAMILY
  • protein kinase superfamily
  • STE Ser/Thr protein kinase family
  • MAP (mitogen activated protein) kinase family
  • mixed-lineage kinase family
  • CATEGORY enzyme , receptor membrane serine/threonine kinase
    SUBCELLULAR LOCALIZATION     plasma membrane
        intracellular
    intracellular,cytoplasm,cytoskeleton,microtubule,centrosome
    basic FUNCTION
  • serine/threonine protein kinase that may contribute to promoting microtubule instability, a hallmark of M phase entry
  • contributing to the TNF signaling pathway that activates JNK
  • required for mitogen activation of BRAF and cell proliferation
  • activates multiple mitogen-activated protein kinase (MAPK) pathways in response to growth factors, stresses and the pro-inflammatory cytokine, tumor necrosis factor (TNF)
  • regulates the MAPKinase pathway activating ERK, MAPK14 and JNK, in response to extracellular signals
  • scaffolding protein, involved in the formation of a multiprotein complex containing MAP3K11/BRAF/RAF1
  • required for optimal activation of stress activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) signaling by TNFA
  • activates multiple MAPK pathways, including the JNK (c-Jun N-terminal kinase) pathway
  • crucial requirement in the migration of invasive breast cancer cells
  • induces luminal repopulation and suppresses the expression of the pro-apoptotic protein BCL2L11 in breast cancer
  • having both a proliferative and antiapoptotic role in the acquisition of a malignant phenotype in mammary epithelial cells
  • is an important regulator of MMP expression and invasion in ovarian cancer cells
  • plays a crucial role in compromising mitochondrial integrity and functions as a proapoptotic competence factor in the early stages of cytokine-induced pancreatic beta cell death
  • promotes saturated fatty acid-induced JNK activation and diet-induced metabolic dysfunction.
  • mitogen-activated protein kinase kinase kinase that activates multiple mitogen-activated protein kinase pathways and has been implicated in regulating proliferation in several cell types
  • is a critical factor controlling the activity of kinase networks that control the cellular responses to different concentrations of ROS
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling signal transduction
  • JNK cascade
  • MAP3K11-PIN1 signaling cascade plays a critical role in regulating the cell cycle, centrosome numbers, and oncogenesis
  • a component
  • MAP3K11-JNK-AP1 signaling is critical for breast cancer cell migration and invasion
  • INTERACTION
    DNA
    RNA
    small molecule
    protein
  • interacting specifically with the GTP bound form of RAC and CDC42, regulators of JNK pathway
  • interacting with GSK3B (cell death induced by GSK3B was mediated by MAP3K11 in a manner dependent on its phosphorylation of the specific residues within the C-terminal domain by GSK3B)
  • activation of MAP3K11 specifically by FGD1/CDC42 is important for skeletal mineralization
  • associates with and uniquely phosphorylates S138 within the PPIase domain of PIN1
  • promotes neointima formation through increased activation of the RHOA pathway in vascular smooth muscle cells
  • direct interaction between PRKAA1 subunit and MAP3K11, and MAP3K11 serves as a common upstream kinase of AMPK and JNK and functions as a direct upstream kinase for AMPK independent of STK11
  • serves as a common upstream kinase of PRKAA1 and JNK and functions as a direct upstream kinase for PRKAA1 independent of STK11
  • ERBB2 activation inhibits the pro-apoptotic function of MAP3K11, which plays a mechanistic role in mediating anti-tumor activities of ERBB2-directed therapies
  • cell & other
    REGULATION
    activated by phosphorylation
    Other activation of MAP3K11 specifically by FGD1/CDC42 is important for skeletal mineralization
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral somatic mutation      
    in MSI gastrointestinal carcinomas
    tumoral     --over  
    in breast cancer cells
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    cancer  
    therapeutics that target MAP3K11 or PIN1 could prove beneficial for a subset of cancers where the MAP3K11-PIN1 pathway is dysregulated
    cancerreproductivebreast
    may be an important therapeutic target for the treatment of invasive breast cancer
    ANIMAL & CELL MODELS